Remove 2021 Remove Cannabinoids Remove Topical
article thumbnail

When adult-use eclipses medical: How recreational cannabis legalization has undermined patient care

The Cannigma

Many physicians remain uninformed about cannabinoid therapies, leaving patients to turn to undertrained budtenders who often prioritize sales over patient care (AJMC, 2022). Dispensary staff, clinicians, and patients alike need comprehensive training on the endocannabinoid system (ECS) and the safe, effective use of cannabinoids.

article thumbnail

Leafreport….”CBD Pricing Report: The Price Difference between the Cheapest and Most Expensive Topicals Increases to 11142%”

Cannabis Law Report

Price Difference between the Cheapest and Most Expensive Topicals Increases to 11142%. Following up on our April 2021 report, Leafreport checked in on CBD pricing again in November 2021. A 2021 survey tells us that CBD attracts users who are seeking natural, holistic products to support their wellness and maintain health.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Motif Labs Announces Launch of Topicals Production Capabilities

Cannabis Law Report

Expanding into the category of market-ready cannabis topicals, the company announces the addition of cannabis-infused body oils, bath oils and balms to their existing vaporizer, concentrate and oil lineup. In 2020, topical sales accounted for over $174 million across the country, a number expected to grow to $227 million in 2021.

article thumbnail

Marijuana Money July 16, 2021

Cannabis Law Report

NASDAQ: OGI) (TSX: OGI) released its results for the third quarter ending May 31, 2021, with revenue growing 31% over last year to $29.1 operating as Audacious (CSE: AUSA) (OTC: AUSAF) is buying a cannabinoid-infused shot beverage company called LOOS. The post Marijuana Money July 16, 2021 appeared first on Green Market Report.

article thumbnail

CBD, THC & CBG for Skin Conditions

Project CBD

Anyone who has paid any attention to the cannabis “wellness” industry in recent years — whether through state medical and recreational programs or the free-for-all national CBD market — will be familiar with cannabinoid-infused topicals marketed to treat minor aches and pains.

article thumbnail

Canada: Medical Cannabis & Cannabinoid Regulation 2021

Cannabis Law Report

24 June 2021. Use of Non-controlled Cannabinoids in Food. The federal Cannabis Act and the regulations enacted thereunder contain extensive provisions relating to how cannabinoids can be incorporated into food and other products. by Matt Maurer , Hunter Forman and Siena Hilley Bland. Torkin Manes LLP. with the authors.

article thumbnail

Heritage Cannabis Enters Exclusive Partnership to Commercialize Avicanna’s Evidence-Based Topical Products through Heritage’s Medical Opticann Brands

Cannabis Law Report

Exclusive licensing of certain of Avicanna’s advanced and evidence-based CBD topical products including its deep tissue and skin care formulations. The Branded Products include Avicanna’s proprietary cannabinoid topical formulations developed through years of extensive research by Avicanna’s team of scientists.